178 related articles for article (PubMed ID: 6130182)
1. Changes in gamma-glutamyltransferase activity during N-2-fluorenylacetamide-induced rat hepatocarcinogenesis.
Capouya ER; Lindahl R
J Natl Cancer Inst; 1983 Feb; 70(2):359-65. PubMed ID: 6130182
[TBL] [Abstract][Full Text] [Related]
2. Activities of benzphetamine N-demethylase and aryl hydrocarbon hydroxylase in cells isolated from gamma-glutamyl transpeptidase-positive foci and surrounding liver.
Hanigan MH; Pitot HC
J Natl Cancer Inst; 1985 Dec; 75(6):1107-12. PubMed ID: 2866268
[TBL] [Abstract][Full Text] [Related]
3. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver.
Lee KW; Wang HJ; Murphy PA; Hendrich S
Nutr Cancer; 1995; 24(3):267-78. PubMed ID: 8610046
[TBL] [Abstract][Full Text] [Related]
4. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules.
Chen ZY; Liu YF; He CY; White CC; Eaton DL
Cancer Res; 1994 May; 54(10):2622-9. PubMed ID: 7909493
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific promoting effects of phenobarbital sodium and sodium saccharin in the induction of liver and urinary bladder tumors in male F344 rats.
Nakanishi K; Fukushima S; Hagiwara A; Tamano S; Ito N
J Natl Cancer Inst; 1982 Mar; 68(3):497-500. PubMed ID: 6950178
[TBL] [Abstract][Full Text] [Related]
7. Expression of H-ras and c-myc protooncogenes in isolated gamma-glutamyl transpeptidase-positive rat hepatocytes and in hepatocellular carcinomas induced by diethylnitrosamine.
Beer DG; Schwarz M; Sawada N; Pitot HC
Cancer Res; 1986 May; 46(5):2435-41. PubMed ID: 2870798
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
Maeura Y; Weisburger JH; Williams GM
Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies on hepatic cirrhosis and hepatocarcinogenesis. II. Influence of cirrhotic liver on 2-FAA hepatocarcinogenesis in rats.
Shimizu A
Acta Pathol Jpn; 1986 Jul; 36(7):1039-48. PubMed ID: 3529810
[TBL] [Abstract][Full Text] [Related]
11. Modifying effects of anticancer drugs adriamycin, actinomycin D, and cisplatin on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
Tanaka T; Takeuchi T; Shimizu M; Morishita Y; Mori Y; Mori H
J Toxicol Environ Health; 1991 Mar; 32(3):269-75. PubMed ID: 2002512
[TBL] [Abstract][Full Text] [Related]
12. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
[TBL] [Abstract][Full Text] [Related]
13. Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms.
Ward JM
J Natl Cancer Inst; 1983 Oct; 71(4):815-23. PubMed ID: 6194333
[TBL] [Abstract][Full Text] [Related]
14. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital.
Hanigan MH; Pitot HC
Cancer Res; 1985 Dec; 45(12 Pt 1):6063-70. PubMed ID: 3904978
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-induced hepatocarcinogenesis: histochemical analysis of ciprofibrate-induced preneoplastic and neoplastic lesions for gamma-glutamyl transpeptidase activity.
Rao MS; Subbarao V; Reddy JK
J Natl Cancer Inst; 1986 Oct; 77(4):951-6. PubMed ID: 2876121
[TBL] [Abstract][Full Text] [Related]
16. Changes in aldehyde dehydrogenase occurring during rat hepatocarcinogenesis induced by ethionine combined with dietary choline deficiency.
Evces S; Lindahl R
Cancer Res; 1986 Jul; 46(7):3587-92. PubMed ID: 2871926
[TBL] [Abstract][Full Text] [Related]
17. Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine.
Russell JJ; Staffeldt EF; Wright BJ; Prapuolenis A; Carnes BA; Peraino C
Cancer Res; 1987 Feb; 47(4):1130-4. PubMed ID: 2879625
[TBL] [Abstract][Full Text] [Related]
18. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
19. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of alpha-fetoprotein and gamma-glutamyltranspeptidase in chemical and spontaneous hepatocarcinogenesis.
Jalanko H; Ruoslahti E
Cancer Res; 1979 Sep; 39(9):3495-501. PubMed ID: 89898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
